PatientsLikeMe : Carbidopa-Levodopa Treatment Evaluations

Search this site
FAQ

Select a community: Parkinson's; Find out more about the PatientsLikeMe
Parkinson's Community

All Communities
Neurological Conditions
MS (Multiple Sclerosis)
Parkinson’s Disease
ALS (Amyotrophic Lateral Sclerosis) / MND (Motor Neuron Disease)
PLS (Primary Lateral Sclerosis)
PMA (Progressive Muscular Atrophy)
PSP (Progressive Supranuclear Palsy)
CBD (Corticobasal Degeneration)
MSA (Multiple System Atrophy)
Devic’s Neuromyelitis Optica
Epilepsy
Neuroendocrine Conditions
Fibromyalgia
CFS (Chronic Fatigue Syndrome) / ME (Myalgic Encephalomyelitis)
Mood Conditions
Anxiety
Bipolar
Depression
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorder
Immune Conditions
HIV/AIDS

Home > Carbidopa-Levodopa Treatment Evaluations

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

One of 52 patient evaluations for Carbidopa-Levodopa

debraread

Sex: F

Data Quality: 3 stars

PD: 3 yrs

Hoehn-Yahr 3

Mouth/throat: mild

Arms: mild

Chest: mild

Legs: mild

See profile
by debraread

current dosage:

25 mg-100 mg daily

time on dosage:

about 2 months

purpose:

Treat Parkinson's

	Treat Parkinson's Efficacy	Side Effects	Adherence	Burden	Specific Side Effects
Dec 17, 2008	Moderate	Moderate	Always	Not at all	Drowsiness on/off time is like a rollercoaster ride Nausea increased sweating

0 helpful marks

Back to top

PatientsLikeMe ™

Carbidopa-Levodopa Treatment Evaluations